Cognition Therapeutics Inc (NAS:CGTX) Stock News, Headlines & Updates
Cognition Therapeutics Inc Stock News from GuruFocus
- 1
Jul 02, 2024
Results from Cognition Therapeutics' Phase 2 SHINE Study of CT1812Â in Mild-to-Moderate Alzheimer's Disease Accepted for Presentation at AAIC
Marketwired • 7:00am
May 21, 2024
Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease
Marketwired • 7:00am
May 07, 2024
Cognition Therapeutics Reports Financial Results for the First Quarter 2024Â and Provides Business Update
Marketwired • 7:00am
Apr 29, 2024
Cognition Therapeutics Completes Enrollment in Phase 2 SHIMMER Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies
Marketwired • 7:00am
Apr 22, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news